Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada flag Canada · Delayed Price · Currency is CAD
0.6500
-0.0400 (-5.80%)
Apr 22, 2026, 12:05 PM EST

TSXV:EBM Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
0.720.780.70.871.30.98
Revenue Growth (YoY)
0.53%11.39%-19.11%-33.22%32.49%36.57%
Cost of Revenue
0.220.230.250.320.40.52
Gross Profit
0.50.550.450.550.90.46
Selling, General & Admin
0.750.770.720.910.90.92
Amortization of Goodwill & Intangibles
0.010.040.110.110.110.11
Operating Expenses
0.760.820.841.021.011.03
Operating Income
-0.27-0.27-0.38-0.47-0.11-0.57
Interest Expense
-0.01-0.01-0.01-0.03-0.01-0
Interest & Investment Income
0-----
Currency Exchange Gain (Loss)
-0.01-0.03-0.01-0.01-0.01-
Other Non Operating Income (Expenses)
-0.03-0.03-0.06-0.03-0.02-0.05
EBT Excluding Unusual Items
-0.31-0.33-0.46-0.55-0.15-0.62
Other Unusual Items
-----0.02
Pretax Income
-0.31-0.33-0.46-0.55-0.15-0.6
Net Income
-0.31-0.33-0.46-0.55-0.15-0.6
Net Income to Common
-0.31-0.33-0.46-0.55-0.15-0.6
Shares Outstanding (Basic)
696969696969
Shares Outstanding (Diluted)
696969696969
EPS (Basic)
-0.00-0.00-0.01-0.01-0.00-0.01
EPS (Diluted)
-0.00-0.00-0.01-0.01-0.00-0.01
Free Cash Flow
0.010.02-0.02-0.02-0.01-0.12
Free Cash Flow Per Share
------0.00
Gross Margin
68.94%70.45%64.72%63.18%69.45%46.72%
Operating Margin
-37.16%-34.13%-54.24%-54.42%-8.60%-58.07%
Profit Margin
-43.40%-42.55%-64.93%-62.98%-11.53%-61.52%
Free Cash Flow Margin
1.99%2.47%-2.17%-1.95%-0.56%-12.41%
EBITDA
-0.26-0.22-0.27-0.42-0.06-0.52
EBITDA Margin
-35.70%-28.38%-38.92%-48.87%-4.97%-53.42%
D&A For EBITDA
0.010.040.110.050.050.05
EBIT
-0.27-0.27-0.38-0.47-0.11-0.57
EBIT Margin
-37.16%-34.13%-54.24%-54.42%-8.60%-58.07%
Revenue as Reported
0.720.780.70.871.30.98
Advertising Expenses
---000.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.